FDA Inspection 1206543 — LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. — FEI 1220948

The FDA completed an inspection of LeMaitre Vascular, Inc. on May 16, 2023 in Burlington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 16, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Burlington, MA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.